CARLSBAD, Calif., June 22, 2016 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) announced today the issuance of its United States Patent No.: 9,364,264 entitled “Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System”. This patent covers Aurora’s family of ZIP® ISPs, including its ZIP Ultra®, ZIP 51™, ZIP LP™ and Dyna-ZIP™ among others.
“Aurora is changing spine surgery, and we are thrilled that our patent has been issued by the United States Patent and Trademark Office (USPTO). This patent further validates the unique and pioneering nature of our ZIP Interspinous implants,” said Trent Northcutt, President and CEO of Aurora Spine and Co-Inventor of the ZIP, “and maintains our position at the forefront, introducing advanced, minimally invasive, disruptive spine surgery technologies.”
“We are very proud of the progress that we have made over the past couple of years in spinal surgery and the remarkable value that Aurora Spine’s intellectual property has added to our company’s growth,” said Laszlo Garamszegi, Chief Technology Officer of Aurora Spine and Co-Inventor of the ZIP.
“Our issued ZIP MIS implant patent provides Aurora Spine with great opportunities to market, license and develop its ONE-STEP™ locking mechanism and screwless implant technology further. Aurora Spine will continue to pursue additional intellectual property rights to unique and disruptive technologies and further develop our patent portfolio as we move forward.”
Aurora has several other U.S. and international patent applications pending related to the ZIP system and its other spinal implant technologies.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to – Simplifying the Complex.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
For more information, please contact: Aurora Spine Corporation Trent Northcutt President and Chief Executive Officer (760) 424-2004 Eric Fronk Chief Financial Officer (760) 424-2004 www.aurora-spine.com
Source:Aurora Spine Corporation